BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Y, Liu Y, Guan X, Kang J, Wang X, Liu Q, Li D, Xu H, Tao Z, Deng Y. Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF-κB and NLRP3 inflammasome. IUBMB Life 2020;72:1065-74. [PMID: 32083808 DOI: 10.1002/iub.2250] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Si Y, Liu L, Cheng J, Zhao T, Zhou Q, Yu J, Chen W, Ding J, Sun X, Lu H, Guo Z. Oral Hydrogen-Rich Water Alleviates Oxalate-Induced Kidney Injury by Suppressing Oxidative Stress, Inflammation, and Fibrosis. Front Med (Lausanne) 2021;8:713536. [PMID: 34490303 DOI: 10.3389/fmed.2021.713536] [Reference Citation Analysis]
2 Gu Y, Shen Y, Chen W, He H, Ma Y, Mei X, Ju D, Liu H. Protective effects of interleukin-22 on oxalate-induced crystalline renal injury via alleviating mitochondrial damage and inflammatory response. Appl Microbiol Biotechnol 2022. [PMID: 35294590 DOI: 10.1007/s00253-022-11876-4] [Reference Citation Analysis]
3 Zhang Y, Ma L, Lu E, Huang W. Atorvastatin Upregulates microRNA-186 and Inhibits the TLR4-Mediated MAPKs/NF-κB Pathway to Relieve Steroid-Induced Avascular Necrosis of the Femoral Head. Front Pharmacol 2021;12:583975. [PMID: 33995003 DOI: 10.3389/fphar.2021.583975] [Reference Citation Analysis]
4 Liu W, Liang L, Zhang Q, Li Y, Yan S, Tang T, Ren Y, Mo J, Liu F, Chen X, Lan T. Effects of andrographolide on renal tubulointersticial injury and fibrosis. Evidence of its mechanism of action. Phytomedicine 2021;91:153650. [PMID: 34332282 DOI: 10.1016/j.phymed.2021.153650] [Reference Citation Analysis]
5 Ding T, Zhao T, Li Y, Liu Z, Ding J, Ji B, Wang Y, Guo Z. Vitexin exerts protective effects against calcium oxalate crystal-induced kidney pyroptosis in vivo and in vitro. Phytomedicine 2021;86:153562. [PMID: 33857849 DOI: 10.1016/j.phymed.2021.153562] [Reference Citation Analysis]
6 Ye T, Yang X, Liu H, Lv P, Lu H, Jiang K, Peng E, Ye Z, Chen Z, Tang K. Theaflavin protects against oxalate calcium-induced kidney oxidative stress injury via upregulation of SIRT1. Int J Biol Sci 2021;17:1050-60. [PMID: 33867828 DOI: 10.7150/ijbs.57160] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yang Y, Wang Q, Wang W, Wei S, Zeng Q, Zhang A. Semaphorin 4A antibody alleviates arsenic-induced hepatotoxicity in mice via inhibition of AKT2/NF-κB inflammatory signaling. Toxicol Appl Pharmacol 2021;410:115364. [PMID: 33290778 DOI: 10.1016/j.taap.2020.115364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Jin X, Jian Z, Chen X, Ma Y, Ma H, Liu Y, Gong L, Xiang L, Zhu S, Shu X, Qi S, Li H, Wang K. Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism. Front Immunol 2021;12:729382. [PMID: 34675921 DOI: 10.3389/fimmu.2021.729382] [Reference Citation Analysis]
9 Sun Y, Kang J, Guan X, Xu H, Wang X, Deng Y. Regulation of endoplasmic reticulum stress on the damage and apoptosis of renal tubular epithelial cells induced by calcium oxalate crystals. Urolithiasis 2021;49:291-9. [PMID: 33786645 DOI: 10.1007/s00240-021-01261-7] [Reference Citation Analysis]
10 Tian L, Liu Y, Xu X, Jiao P, Hu G, Cui Y, Chen J, Ma Y, Jin X, Wang K, Sun Q. Lactiplantibacillus plantarum J-15 reduced calcium oxalate kidney stones by regulating intestinal microbiota, metabolism, and inflammation in rats. FASEB J 2022;36:e22340. [PMID: 35524736 DOI: 10.1096/fj.202101972RR] [Reference Citation Analysis]
11 Crestani T, Crajoinas RO, Jensen L, Dima LL, Burdeyron P, Hauet T, Giraud S, Steichen C. A Sodium Oxalate-Rich Diet Induces Chronic Kidney Disease and Cardiac Dysfunction in Rats. Int J Mol Sci 2021;22:9244. [PMID: 34502149 DOI: 10.3390/ijms22179244] [Reference Citation Analysis]
12 Tzelves L, Mourmouris P, Skolarikos A. Outcomes of dissolution therapy and monitoring for stone disease: should we do better? Curr Opin Urol 2021;31:102-8. [PMID: 33332876 DOI: 10.1097/MOU.0000000000000844] [Reference Citation Analysis]